Breatheox Limited
11076848
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 05/09/2024
CEO AND CO-FOUNDER, DEVPRO BIOPHARMA
AMERICAN · UNITED STATES · Age 62
Persons with Significant Control
Mikesh Udani
Indian · United Kingdom · Age 38
9400, Garsington Road, Oxford, OX4 2HN
Notified 27/03/2019
Former PSCs
The Chancellor, Masters And Scholars Of The University Of Oxford
Ceased 31/03/2023
CompanyRankvs 28790+ SIC 86900 peers59
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£5k
Balance sheet strength
Cash
£306k
Cash in the bank
Net Current Assets
-£526k
Working capital
Current Assets
£2.4M
Current Liabilities
£3.0M
Fixed Assets
£73k
Debtors
£1.9M
Profit After Tax
-£1.0M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.82 | -£254k |
| 2024 | 1.52 | -£765k |
| 2023 | 6.04 | — |
Derived from filed accounts. Not audited figures.